CRH Medical Corporation, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, has entered into an agreement with The Bank of Nova Scotia (Scotiabank) for a U.S.$55M senior secured revolving syndicated credit facility. The facility was increased from U.S.$33M to U.S.$55M and now includes US Bank National Association as a partner to CRH and Scotiabank.

The additional credit facility will be used to fund future acquisitions. The interest for the facility is calculated using a set formula with a base rate plus 2.5% - 3.0%, depending on the company's total debt to EBITDA ratio. Under the facility, using the current base rate, CRH has an expected total interest cost currently of approximately 3.50% per annum. The facility matures on April 30, 2018 and is self-amortizing with fixed quarterly repayments of approximately 5% of the outstanding balance each quarter.

"CRH has now demonstrated a series of disciplined, accretive acquisitions, which has benefited both our shareholders and our creditors. Our financial strength has allowed us to expand our access to relatively low cost, non-dilutive capital in order to maintain our pace and size of accretive acquisitions. We are pleased to have partnered and grown with Scotiabank and to have also added a new partner in U.S. Bank," stated Richard Bear, Chief Financial Officer.

Key benefits of the Scotiabank/U.S. Bank credit facility:

• Expanded Facility provides flexibility to CRH for additional acquisitions
• Maintained at an attractive interest rate, currently at approximately 3.50% per annum
• Additional acquisitions likely to be immediately accretive to cash flow, EBITDA and earnings
• Provides credit framework for CRH to grow to the next level of critical mass

CEO of CRH, Edward Wright added "In relatively short order we have established the support from the capital markets with the accompanying, appropriate financial tools from premier banking institutions Scotiabank and U.S. Bank to help us execute on a vision of strong growth for CRH. We continue to be in active discussions with a significant pipeline of acquisition opportunities."

CRH Medical Corporation is a North American company focused on providing physicians with innovative services and products for the treatment of gastrointestinal diseases.